{"id":409335,"date":"2021-01-06T08:03:19","date_gmt":"2021-01-06T13:03:19","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=409335"},"modified":"2021-01-06T08:03:19","modified_gmt":"2021-01-06T13:03:19","slug":"f-star-therapeutics-to-participate-in-upcoming-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-participate-in-upcoming-conferences\/","title":{"rendered":"F-star Therapeutics to Participate in Upcoming Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Jan.  06, 2021  (GLOBE NEWSWIRE) &#8212; F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to\u00a0developing next generation immunotherapies to transform the lives of patients with cancer, today announces that members of the management team will be participating in the H.C. Wainwright BioConnect Conference, the LifeSci Advisors 10th Annual Corporate Access Event and the B Riley Oncology Event. All events will take place virtually.<\/p>\n<p>Details for the events are as follows:<\/p>\n<p>\n        <strong>H.C. Wainwright BioConnect Conference<\/strong>\n      <\/p>\n<p>Fireside chat with CEO, Eliot Forster<br \/>Dates: January 11-14, 2021<\/p>\n<p>\n        <strong>LifeSci Advisors 10th Annual Corporate Access Event<\/strong>\n      <\/p>\n<p>1&#215;1 Meetings with Management<br \/>Dates: January 6-8, 11-14, 2021<\/p>\n<p>\n        <strong>B Riley Oncology Investor Conference<\/strong>\n      <\/p>\n<p>Presentation by CEO, Eliot Forster<br \/>Date: January 20, 2021<br \/>Time: 11:30am \u2013 12:00pm<\/p>\n<p>\n        <strong>Eliot Forster, CEO of F-star Therapeutics, Inc., said<\/strong>: \u201cHaving listed on NASDAQ at the end of 2020, we are looking forward to the opportunity to discuss the Company, our pipeline and our most recent progress at these events. We have had numerous updates across our four clinical programs in recent months and continue our dedication to developing next generation immunotherapies to transform the lives of patients with cancer.\u201d<\/p>\n<p align=\"justify\">\n        <strong>About F-star Therapeutics, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">F-star is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumor immune evasion, the Company\u2019s goal is to offer patients greater and more durable benefits than current immuno-oncology treatments. Through its proprietary tetravalent, bispecific natural antibody (mAb\u00b2\u2122) format, F-star\u2019s mission is to generate highly differentiated best-in-class drug candidates with monoclonal antibody-like manufacturability. For more information visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bh_PfoD2ber93WM53Xb3G-OUo6Fyh5vOBSzZNkxxxPkGTtNAtqrzJZsqATshd3nF7itJ_ILF5h7MEHTMkKfEDg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.f-star.com<\/u><\/a>.<\/p>\n<p>\n        <strong>For further information, please contact:<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">\n            <strong>For investor inquiries <\/strong><br \/>\n            <br \/>\n            <strong>Lindsey Trickett<\/strong><br \/>\n            <br \/>VP Investor Relations &amp; Communications<br \/>+1 240 543 7970<br \/><a href=\"mailto:lindsey.trickett@f-star.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>lindsey.trickett@f-star.com<\/u><\/a><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">\n            <strong>For media inquiries <\/strong><br \/>\n            <br \/>\n            <strong>Next Step Communications<\/strong><br \/>\n            <br \/>Nigel Smith<br \/>+1 781 326 1741<br \/><a href=\"mailto:F-star@nextstepcomms.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>F-star@nextstepcomms.com<\/u><\/a><\/td>\n<\/tr>\n<\/table>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTA2OCMzOTA1NjY2IzIyMDI3NjA=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/7a302f24-b8dd-45b6-8e0c-3601602637fa\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) &#8212; F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to\u00a0developing next generation immunotherapies to transform the lives of patients with cancer, today announces that members of the management team will be participating in the H.C. Wainwright BioConnect Conference, the LifeSci Advisors 10th Annual Corporate Access Event and the B Riley Oncology Event. All events will take place virtually. Details for the events are as follows: H.C. Wainwright BioConnect Conference Fireside chat with CEO, Eliot ForsterDates: January 11-14, 2021 LifeSci Advisors 10th Annual Corporate Access Event 1&#215;1 Meetings with ManagementDates: January 6-8, 11-14, 2021 B Riley Oncology Investor Conference Presentation by CEO, Eliot ForsterDate: January 20, 2021Time: 11:30am &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-participate-in-upcoming-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;F-star Therapeutics to Participate in Upcoming Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-409335","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>F-star Therapeutics to Participate in Upcoming Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-participate-in-upcoming-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"F-star Therapeutics to Participate in Upcoming Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) &#8212; F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to\u00a0developing next generation immunotherapies to transform the lives of patients with cancer, today announces that members of the management team will be participating in the H.C. Wainwright BioConnect Conference, the LifeSci Advisors 10th Annual Corporate Access Event and the B Riley Oncology Event. All events will take place virtually. Details for the events are as follows: H.C. Wainwright BioConnect Conference Fireside chat with CEO, Eliot ForsterDates: January 11-14, 2021 LifeSci Advisors 10th Annual Corporate Access Event 1&#215;1 Meetings with ManagementDates: January 6-8, 11-14, 2021 B Riley Oncology Investor Conference Presentation by CEO, Eliot ForsterDate: January 20, 2021Time: 11:30am &hellip; Continue reading &quot;F-star Therapeutics to Participate in Upcoming Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-participate-in-upcoming-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-06T13:03:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTA2OCMzOTA1NjY2IzIyMDI3NjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/f-star-therapeutics-to-participate-in-upcoming-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/f-star-therapeutics-to-participate-in-upcoming-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"F-star Therapeutics to Participate in Upcoming Conferences\",\"datePublished\":\"2021-01-06T13:03:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/f-star-therapeutics-to-participate-in-upcoming-conferences\\\/\"},\"wordCount\":301,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/f-star-therapeutics-to-participate-in-upcoming-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTA2OCMzOTA1NjY2IzIyMDI3NjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/f-star-therapeutics-to-participate-in-upcoming-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/f-star-therapeutics-to-participate-in-upcoming-conferences\\\/\",\"name\":\"F-star Therapeutics to Participate in Upcoming Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/f-star-therapeutics-to-participate-in-upcoming-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/f-star-therapeutics-to-participate-in-upcoming-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTA2OCMzOTA1NjY2IzIyMDI3NjA=\",\"datePublished\":\"2021-01-06T13:03:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/f-star-therapeutics-to-participate-in-upcoming-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/f-star-therapeutics-to-participate-in-upcoming-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/f-star-therapeutics-to-participate-in-upcoming-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTA2OCMzOTA1NjY2IzIyMDI3NjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTA2OCMzOTA1NjY2IzIyMDI3NjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/f-star-therapeutics-to-participate-in-upcoming-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"F-star Therapeutics to Participate in Upcoming Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"F-star Therapeutics to Participate in Upcoming Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-participate-in-upcoming-conferences\/","og_locale":"en_US","og_type":"article","og_title":"F-star Therapeutics to Participate in Upcoming Conferences - Market Newsdesk","og_description":"CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) &#8212; F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to\u00a0developing next generation immunotherapies to transform the lives of patients with cancer, today announces that members of the management team will be participating in the H.C. Wainwright BioConnect Conference, the LifeSci Advisors 10th Annual Corporate Access Event and the B Riley Oncology Event. All events will take place virtually. Details for the events are as follows: H.C. Wainwright BioConnect Conference Fireside chat with CEO, Eliot ForsterDates: January 11-14, 2021 LifeSci Advisors 10th Annual Corporate Access Event 1&#215;1 Meetings with ManagementDates: January 6-8, 11-14, 2021 B Riley Oncology Investor Conference Presentation by CEO, Eliot ForsterDate: January 20, 2021Time: 11:30am &hellip; Continue reading \"F-star Therapeutics to Participate in Upcoming Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-participate-in-upcoming-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-06T13:03:19+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTA2OCMzOTA1NjY2IzIyMDI3NjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-participate-in-upcoming-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-participate-in-upcoming-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"F-star Therapeutics to Participate in Upcoming Conferences","datePublished":"2021-01-06T13:03:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-participate-in-upcoming-conferences\/"},"wordCount":301,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-participate-in-upcoming-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTA2OCMzOTA1NjY2IzIyMDI3NjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-participate-in-upcoming-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-participate-in-upcoming-conferences\/","name":"F-star Therapeutics to Participate in Upcoming Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-participate-in-upcoming-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-participate-in-upcoming-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTA2OCMzOTA1NjY2IzIyMDI3NjA=","datePublished":"2021-01-06T13:03:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-participate-in-upcoming-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-participate-in-upcoming-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-participate-in-upcoming-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTA2OCMzOTA1NjY2IzIyMDI3NjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTA2OCMzOTA1NjY2IzIyMDI3NjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/f-star-therapeutics-to-participate-in-upcoming-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"F-star Therapeutics to Participate in Upcoming Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/409335","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=409335"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/409335\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=409335"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=409335"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=409335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}